These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 7484908)

  • 1. Combination of lovastatin, enalapril, and colchicine does not prevent restenosis after percutaneous transluminal coronary angioplasty.
    Freed M; Safian RD; O'Neill WW; Safian M; Jones D; Grines CL
    Am J Cardiol; 1995 Dec; 76(16):1185-8. PubMed ID: 7484908
    [No Abstract]   [Full Text] [Related]  

  • 2. Enalapril for prevention of restenosis after coronary angioplasty.
    Kaul U; Chandra S; Bahl VK; Sharma S; Wasir HS
    Indian Heart J; 1993; 45(6):469-73. PubMed ID: 8070823
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacologic prevention of restenosis after coronary angioplasty: review of the randomized clinical trials.
    Franklin SM; Faxon DP
    Coron Artery Dis; 1993 Mar; 4(3):232-42. PubMed ID: 8269217
    [No Abstract]   [Full Text] [Related]  

  • 4. Lovastatin plus probucol for prevention of restenosis after percutaneous transluminal coronary angioplasty.
    O'Keefe JH; Stone GW; McCallister BD; Maddex C; Ligon R; Kacich RL; Kahn J; Cavero PG; Hartzler GO; McCallister BD
    Am J Cardiol; 1996 Mar; 77(8):649-52. PubMed ID: 8610621
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of angiotensin converting enzyme inhibition on the incidence of restenosis after percutaneous transluminal coronary angioplasty.
    Brozovich FV; Morganroth J; Gottlieb NB; Gottlieb RS
    Cathet Cardiovasc Diagn; 1991 Aug; 23(4):263-7. PubMed ID: 1653645
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevention of restenosis after coronary balloon angioplasty: rationale and design of the Fluvastatin Angioplasty Restenosis (FLARE) Trial. The FLARE Study Group.
    Foley DP; Bonnier H; Jackson G; Macaya C; Shepherd J; Vrolix M; Serruys PW
    Am J Cardiol; 1994 May; 73(14):50D-61D. PubMed ID: 8198025
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relation of lumen size to restenosis after percutaneous transluminal coronary balloon angioplasty. Lovastatin Restenosis Trial Group.
    Waksman R; Kosinski AS; Klein L; Boccuzzi SJ; King SB; Ghazzal ZM; Weintraub WS
    Am J Cardiol; 1996 Jul; 78(2):221-4. PubMed ID: 8712148
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Background and methods for the lovastatin restenosis trial after percutaneous transluminal coronary angioplasty. The Lovastatin Restenosis Trial Study Group.
    Weintraub WS; Boccuzzi SJ; Brown CL; Cohen CL; Hirsch LJ; King SB; Alexander RW
    Am J Cardiol; 1992 Aug; 70(3):293-9. PubMed ID: 1632391
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacogenetic analysis of the effect of angiotensin-converting enzyme inhibitor on restenosis after percutaneous transluminal coronary angioplasty.
    Okamura A; Ohishi M; Rakugi H; Katsuya T; Yanagitani Y; Takiuchi S; Taniyama Y; Moriguchi K; Ito H; Higashino Y; Fujii K; Higaki J; Ogihara T
    Angiology; 1999 Oct; 50(10):811-22. PubMed ID: 10535720
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of residual plaque burden after balloon angioplasty in the MultiVitamins and Probucol (MVP) trial.
    Tardif JC; Côté G; Lespérance J; Gosselin G; Joyal M; de Guise P; Bilodeau L; Doucet S; Harel F; Couturier A; Gallo R; Grégoire J
    Can J Cardiol; 2001 Jan; 17(1):49-55. PubMed ID: 11173314
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lack of effect of lovastatin on restenosis after coronary angioplasty. Lovastatin Restenosis Trial Study Group.
    Weintraub WS; Boccuzzi SJ; Klein JL; Kosinski AS; King SB; Ivanhoe R; Cedarholm JC; Stillabower ME; Talley JD; DeMaio SJ
    N Engl J Med; 1994 Nov; 331(20):1331-7. PubMed ID: 7935702
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Percutaneous transluminal angioplasty and restenosis--working hypothesis and treatment approaches].
    Roeren T
    Rontgenpraxis; 1996 Feb; 49(2):31-4. PubMed ID: 8851545
    [No Abstract]   [Full Text] [Related]  

  • 13. Restenosis after percutaneous transluminal coronary angioplasty.
    Pedersen HK; Vatne K; Simonsen S
    Acta Radiol; 1992 Mar; 33(2):149-51. PubMed ID: 1562409
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Costs of coronary restenosis (Lovastatin Restenosis Trial).
    Gilbert SP; Weintraub WS; Talley JD; Boccuzzi SJ
    Am J Cardiol; 1996 Jan; 77(2):196-9. PubMed ID: 8546093
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Harmful effect of enalapril on left ventricular remodelling in patients without a severe residual stenosis after acute anterior wall infarction?
    Kjøller-Hanson L
    Eur Heart J; 1998 Jun; 19(6):969. PubMed ID: 9651724
    [No Abstract]   [Full Text] [Related]  

  • 16. [Restenosis after percutaneous transluminal coronary angioplasty].
    Haze K
    Kokyu To Junkan; 1989 Dec; 37(12):1283-93. PubMed ID: 2616905
    [No Abstract]   [Full Text] [Related]  

  • 17. [Management of stable coronary artery disease].
    Jacobshagen C; Hasenfuss G
    MMW Fortschr Med; 2009 Nov; 151(47):45-9; quiz 50. PubMed ID: 20037979
    [No Abstract]   [Full Text] [Related]  

  • 18. [Stable ischemic coronary disease--medical therapy or PCI?].
    Mickley H; Egstrup K
    Ugeskr Laeger; 2007 Jun; 169(23):2227. PubMed ID: 17607849
    [No Abstract]   [Full Text] [Related]  

  • 19. Antithrombin III supplementation for patients undergoing PTCA for unstable angina pectoris. A controlled randomized double-blind pilot study.
    Grip L; Blombäck M; Egberg N; Olsson A; Svane B; Velander M
    Eur Heart J; 1997 Mar; 18(3):443-9. PubMed ID: 9076381
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Staphylococcal pericarditis following percutaneous transluminal coronary angioplasty.
    Sankari A; Kumar AN; Kabins S; Chandna H; Lieb D
    Catheter Cardiovasc Interv; 2000 May; 50(1):71-3. PubMed ID: 10816285
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.